CryoLife completes acquisition of Jotec

141

CryoLifeCryoLife, Inc, a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that it has completed its previously announced acquisition of Jotec AG, a German-based, privately-held developer of technologically differentiated endovascular stent grafts, and cardiac and vascular surgical grafts, focused on aortic repair.

The deal was first announced in October.

Jotec generated revenue of approximately €41 million in 2016, representing compound annual growth of approximately 17% over the preceding five years. Jotec generated revenues of €43 million for the twelve months ended 30 June, 2017.

(Visited 96 times, 1 visits today)

LEAVE A REPLY

Please enter your comment!
Please enter your name here